UK-focused funds shed £448m
Fundamental research is imperative as growth weakens.
'Sticky' inflation could see Fed rethink
Spoke at the Economic Club of Washington
Following Boris Johnson dropping out
Fuelled by innovation, the outlook for the biotech sector remains positive and should be viewed separately from the macro environment, says Peter Hughes.